{"id":"W4378802651","doi":"10.1200/jco.22.02200","title":"Children's Oncology Group AALL1331: Phase III Trial of Blinatumomab in Children, Adolescents, and Young Adults With Low-Risk B-Cell ALL in First Relapse","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":93,"is_retracted":false,"has_abstract":true,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Cancer Institute; Seattle Children's Research Institute; Children's Hospital of Philadelphia","keywords":"Blinatumomab; Medicine; Chemotherapy; Internal medicine; Oncology; Leukemia; Surgery; Lymphoblastic Leukemia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001076021,0.0009356037,0.001327115,0.0002949971,0.0004798371,0.0006550879,0.000768402,0.0007254065,0.002553789],"category_scores_gemma":[0.0004861182,0.000355443,0.0007371465,0.000334162,0.0007038876,0.0003833589,0.0004114453,0.002678452,0.0005075156],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001387552,"about_ca_system_score_gemma":0.002939824,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003877197,"about_ca_topic_score_gemma":0.01546255,"domain_scores_codex":[0.9996799,0.0001653349,0.0000102141,0.0000365807,0.00003156808,0.00007636341],"domain_scores_gemma":[0.9994316,0.00005996802,0.0001235183,0.00002721537,0.00001937493,0.0003382534],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7658355,0.04974713,0.02548802,0.001017942,0.001099098,0.0003088301,0.0004792934,0.002106467,0.02332235,0.0006032816,0.01177026,0.1182219],"study_design_scores_gemma":[0.6373503,0.3058703,0.04105052,0.0001600981,0.0006276537,0.000413357,0.0001396029,0.001066918,0.00396095,0.0002287062,0.009092753,0.00003881276],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9928024,0.002470713,0.0001383027,0.0005544746,0.00008902367,0.001510008,0.000981606,0.00004904576,0.001404308],"genre_scores_gemma":[0.9832449,0.003653224,0.001561329,0.001142452,0.0001850473,0.003882263,0.002467348,0.00002883748,0.003834637],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003877197,"threshold_uncertainty_score":0.01006746,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03294594451113258,"score_gpt":0.397294345372739,"score_spread":0.3643484008616064,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}